rs1060503180
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_017780.4(CHD7):c.5211-1G>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_017780.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.5211-1G>C | splice_acceptor_variant, intron_variant | Intron 23 of 37 | 5 | NM_017780.4 | ENSP00000392028.1 | |||
CHD7 | ENST00000524602.5 | c.1717-13715G>C | intron_variant | Intron 2 of 4 | 1 | ENSP00000437061.1 | ||||
CHD7 | ENST00000695853.1 | n.5211-1G>C | splice_acceptor_variant, intron_variant | Intron 23 of 36 | ENSP00000512218.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
CHARGE syndrome Pathogenic:1
This sequence change affects an acceptor splice site in intron 23 of the CHD7 gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. Truncating variants in CHD7 are known to be pathogenic (PMID: 16400610, 22461308). This particular variant was reported in an individual with CHARGE syndrome (PMID: 22461308). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at